coumermycin may be considered as treatments for Lyme disease.
Lyme disease, a common tick-borne disorder with a variety of clinical symptoms (28) , is caused by the spirochete Borrelia burgdorfien (6) . The genome of B. burgdorfen is unusual among eubacteria in that it consists of both crosslinked linear and supercoiled circular DNA molecules (2, 3, 15, 16, 27) . In addition, the chromosome of B. burgdorfen is linear (4, 5, 7, 12) .
The DNA of eubacteria is in a state of torsional stress termed negative supercoiling, in which the double helix is slightly underwound (8, 9, 23, 30, 31) . The degree of supercoiling is modulated by the opposed activities of DNA topoisomerase I and DNA gyrase, as well as by the transcriptional machinery (8, 9, 18, 21) . DNA gyrase catalyzes the introduction of negative superhelical tension into DNA (13, 23) . The enzyme is a tetramer composed of two subunits (A2B2): subunit A binds DNA and subunit B hydrolyzes ATP (13, 23) . DNA gyrase is required for bacterial DNA replication and functions in gene expression as well as other elements of macromolecular DNA metabolism (8, 9, 21, 23, 30, 31) .
Several antimicrobial agents specifically target DNA gyrase (10, 17, 22, 23, 32) . We have investigated the activity of coumermycin A1 and other DNA gyrase inhibitors on B. burgdorferi because of our interest in probing the role of DNA gyrase and understanding the structure of chromatin in a bacterium with linear DNA molecules. We have found that B. burgdorferi is susceptible to growth inhibition and circular plasmid relaxation by coumermycin.
MATERIALS AND METHODS
Bacteria and growth assay. B. burgdorfen B31 (the type species, ATCC 35210) was grown at 34°C in BSK II medium (1) lacking gelatin. This strain has been extensively passaged in culture; it contains four linear plasmids (with sizes of 15.5, 27.1, 37.5 and 50.1 kb) and three covalently closed circular plasmids (with sizes of 8, 26.2, and 29.3 kb) but no longer * Corresponding author. synthesizes a typical OspB protein (data not shown). Growth was assayed by inoculating and growing 10-ml cultures, centrifuging the cells, resuspending them in 1 ml of Dulbecco's phosphate-buffered saline (PBS), and determining the optical density at 600 nm (1 unit of which was equivalent to 1.4 x 109 bacteria per ml) (26) . The MIC was determined by inoculating 10 ml of BSK II medium with 106 bacteria per ml in the presence or absence of antibiotics, incubating the mixture at 34°C until the cultures in the absence of antibiotics reached approximately 1.5 x 108 bacteria per ml (usually 72 h), and assaying growth by determining the optical density at 600 nm. MIC was defined as the concentration of antibiotic that inhibited growth by 90% relative to growth in the absence of antibiotic. At the MIC, there were no visual signs of growth and no change in the color of the medium.
Antibiotics and enzymes. Coumermycin A1 (also referred to as coumermycin; Sigma) at 50 mg/ml in dimethyl sulfoxide (DMSO), novobiocin (Boehringer Mannheim) and ciprofloxacin (Sigma) at 25 mg/ml in H20, and nalidixic acid (United States Biochemical) and oxolinic acid (Sigma) at 50 mg/ml in 0.5 N NaOH were stored at -70°C. Antibiotics were added directly to B. burgdorfen cultures inoculated with 106 bacteria per ml in BSK II medium, unless otherwise noted (yielding a final DMSO concentration of 0.01%). Purified calf thymus DNA topoisomerase I (30 U; GIBCO BRL) and purified Micrococcus luteus DNA gyrase (20 U; GIBCO BRL) were incubated with 20 ,ug of DNA for 1 h at 37°C in 20 ,ul of 40 mM Tris-HCl (pH 7.5)-15 mM KCl-10 mM MgCl2-1.5 mM dithiothreitol-40 ,ug of bovine serum albumin per ml. DNA gyrase and control reaction mixtures also contained 1.5 mM ATP and 5 mM spermidine.
DNA purification. DNA was isolated from B. burgdorfien by a modification of a previously described protocol (24) . Bacteria from 10-ml cultures were washed with 1 ml of PBS and resuspended in 0.2 ml of 50 mM Tris-HCl (pH 8.0)-50 mM EDTA-15% sucrose. The cells were lysed by adding 23 pl of 10% sodium dodecyl sulfate and incubated at 37°C for 30 min after 3 pl of 20-mg/ml proteinase K solution was added. The lysate was extracted once with an equal volume 47 of phenol-chloroform-isoamyl alcohol (25:24:1). Nucleic acid was precipitated by adding 8,ul of 5 M NaCl and 0.4 ml of ethanol at -20°C. For some experiments, samples were then treated with RNase A, extracted, and precipitated again.
Agarose gel electrophoresis. The DNA was heated to 60°C in 1% N-lauroylsarcosine-10 mM EDTA-3% Ficoll 400-0.05 mg of bromophenol blue per ml-0.05 mg of xylene cyanol per ml for 2 min, cooled briefly, and fractionated on 0.35% agarose gels (SeaKem GTG; FMC Bioproducts) in TAE (40 mM Tris, 20 mM acetate, 1 mM EDTA) at 12 V (0.4 V/cm) for 48 h. The gels were stained in 0.5 ,ug of ethidium bromide per ml for 1 h, destained in water for 1 h, visualized on a UJV transilluminator (Foto UV 310; Fotodyne), and photographed through a 23A filter (series 7; Tiffen) and 5 mm of UV opaque plexiglass (UviCover I; Fotodyne) with type 55 film (Polaroid). For the two-dimensional gel (20) , DNA was fractionated in the first dimension as described above except that electrophoresis was carried out for 16 h. The gel was then rotated 900 and equilibrated with 15 ,uM chloroquine in TAE for 5 h. Electrophoresis was continued for 16 h in the presence of 15 ,uM chloroquine. The gel was destained in three changes of water (>1 h each) to remove chloroquine before being stained with ethidium bromide. Molecular weight standards were either lambda DNA-HindIII digest or lambda DNA-Mono Cut Mix (New England BioLabs).
RESULTS
Inhibition of growth by coumermycin. Several gyrase inhibitors were examined for their effect on the growth of B. burgdorferi in BSK II medium. Included were the DNA gyrase subunit B inhibitors coumermycin and novobiocin, as well as the subunit A inhibitors ciprofloxacin, nalidixic acid, and oxolinic acid. B. burgdorferi B31 was found to be particularly susceptible to coumermycin ( Fig. 1) , with a MIC of 0.2 ,ug/ml. This degree of susceptibility was not seen with nalidixic acid, oxolinic acid, or ciprofloxacin. Nalidixic acid at 300 p,g/ml, the maximum concentration tested, inhibited the relative growth of B. burgdorferi in BSK II medium by only 50% (data not shown). The MICs of oxolinic acid, ciprofloxacin, and novobiocin for B. burgdorferi B31 were 100, 2, and 5 ,ug/ml, respectively (data not shown).
Relaxation of supercoiled plasmids by slightly inhibitory doses of coumermycin. Two-dimensional agarose gel electrophoresis was used to examine the effect of coumermycin on plasmid DNA topology in B. burgdorferi, since coumermycin treatment has previously been shown to induce the relaxation of supercoiled DNA molecules in Escherichia coli via inhibiting DNA gyrase (11, 14, 29) . The second dimension was run in the presence of chloroquine, which unwinds the helix and retards the migration of negatively supercoiled closed circular DNA. The migration of linear DNA is not affected by chloroquine, resulting in a diagonal pattern following two-dimensional gel electrophoresis. This analysis revealed the presence of two negatively supercoiled plasmids with approximate sizes of 26 and 29 kb (Fig. 2, lane 1) . The 8-kb supercoiled plasmid was not visualized in these experiments. Treatment of B. burgdorferi with coumermycin induced the relaxation of these two plasmids (Fig. 2, lane 2) . DNA ation in E. coli, but low concentrations actually increase supercoiling, because of increased DNA gyrase expression (10) . Plasmid relaxation, assayed in a conventional gel electrophoresis system by the absence of the supercoiled form, was induced by treatment of B. burgdorferi cells with 0.003 ,ug of coumermycin per ml (Fig. 3, lane 6) , a dose that only slightly inhibits growth (Fig. 1 ). However, we have not observed increased supercoiling at any concentration of coumermycin tested from 0.00001 to 0.001 ,ug/ml (Fig. 3 , lanes 2 to 5, and data not shown), although we have not been able to resolve individual topoisomers. Novobiocin, but not ciprofloxacin, nalidixic acid, or oxolinic acid, also induced the relaxation of the circular DNA molecules (data not shown), consistent with the case for E. coli (10) . Relaxation was detectable within 1 h after the beginning of coumermycin treatment (Fig. 4, lane 3) and was complete within 2 h (Fig. 4, lane 4) .
Supercoiling of relaxed plasmids in vivo and in vitro. We employed four independent strategies to demonstrate that the supercoiled plasmids were relaxed, rather than lost, after coumermycin treatment. First, removing coumermycin from the treated cultures by centrifugation and resuspension resulted in resupercoiling of the relaxed plasmids in vivo (Fig. 5 ). Plasmid supercoiling began at about 1 h (Fig. 5, lane  3) and was nearly complete after 2 h of chase (Fig. 5, lane 5) . This timing was similar to that for plasmid relaxation (Fig. 4) and may reflect the kinetics of B. burgdorferi DNA gyrase in vivo.
Second, DNA isolated from untreated cells and from cells treated with slightly inhibitory doses of coumermycin was treated with exogenous DNA topoisomerase I and exogenous DNA gyrase (Fig. 6 ). DNA topoisomerase I can relax supercoiled DNA but cannot supercoil DNA, while DNA gyrase can supercoil DNA in an ATP-dependent fashion. Purified DNA topoisomerase I relaxed the two negatively supercoiled circular plasmids in vitro (Fig. 6, lanes 1 and 2) , resulting in the profile generated by coumermycin treatment (Fig. 6, lane 4) ; this enzyme, however, had no effect on the relaxed DNA from coumermycin-treated cells (Fig. 6 , lane ). In contrast, DNA gyrase plus ATP had no effect on the supercoiled plasmids (Fig. 6, lane 3) but was able to resupercoil in vitro the circular plasmids relaxed by coumermycin treatment (Fig. 6, lanes 4 and 6) . DNA gyrase did not restore supercoiling to all of the circular plasmids of each (lanes 1 and 4) , purified DNA topoisomerase I (Topo I; lanes 2 and 5), or ATP and purified DNA gyrase (lanes 3 and 6). Reaction mixtures were subjected to 0.35% agarose gel electrophoresis, and DNA was visualized by staining with ethidium bromide. The supercoiled forms of the 26-and 29-kb circular plasmids are indicated by arrows. Molecular size markers (in kilobases) are indicated on the left. size (Fig. 6, lanes 1 and 6) , probably because relaxed plasmids are more susceptible to nicking during isolation than supercoiled plasmids, because of their less compact conformation.
Third, electron microscopy of DNA preparations showed that the circular DNA molecules were relaxed (19) . Fourth, the 29-kb circular plasmid was used to probe a Southern blot of DNA from coumermycin-treated B. burgdorferi. This experiment revealed that the relaxed form migrated with an apparent size of approximately 50 kb, and visualization of this 29-kb circular plasmid topoisomer by ethidium bromide staining was obscured by the 50-kb linear plasmid (data not shown).
DISCUSSION
B. burgdorferi was more susceptible to growth inhibition and plasmid relaxation by coumermycin than were many other bacteria (32) . The MIC for susceptible strains of E. coli is 15 ,ug/ml (14) , making B. burgdorfen about 100 times more susceptible. Unfortunately, coumermycin is not a clinically useful antibiotic because of its insolubility, poor absorption, and high serum inactivation (22) . Further work on the development of structural analogs that do not have these problems may yield an effective treatment for Lyme disease. B. burgdorferi was also susceptible to the coumarin antibiotic novobiocin but relatively resistant to the quinolone antimicrobial agents. The MIC of nalidixic acid was greater than 300 pg/ml for B. burgdorferi but only 8 pg/ml for E. coli, and the MIC of ciprofloxacin was 100-fold higher for B. burgdorferi than for E. coli (32) . Preliminary results indi-cated that E. coli was less susceptible to coumermycin, oxolinic acid, and nalidixic acid (but not ciprofloxacin) in BSK II medium than in Luria-Bertani medium (25) .
The increased levels of supercoiling at low concentrations of coumermycin that are found in E. coli (10) were not observed in B. burgdorferi. Perhaps the genes encoding DNA gyrase in B. burgdorferi are not regulated by supercoiling, or the topology of the chromosome is not affected by coumermycin treatment. In E. coli, coumermycin induces DNA relaxation in 20 min, an interval nearly equal to the generation time (11) . In contrast, plasmid relaxation and supercoiling in B. burgdorferi B31, an organism with a generation time of approximately 12 h, required about 2 h. Therefore, relaxation in B. burgdorferi does not appear to be coupled directly to the replication cycle but may be mediated by DNA topoisomerase I activity or active transcription.
Taken together, the results of these experiments suggest that B. burgdorferi possesses a DNA gyrase that acts on the circular DNA molecules and is required for growth. In addition to providing a target for effective antimicrobial agents, we currently are interested in whether DNA gyrase also functions on the linear DNA molecules, where nearly all genes mapped to date in B. burgdorferi are located. Coumermycin will be used to dissect the mechanism of DNA replication as well as the factors that influence the regulation of gene expression.
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